Robert Newton

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 559 citations · Full text

Medicine, Immunology, Oncology +14

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

Stefani Spranger, Holly K. Koblish, Brendan Horton et al. · Journal for ImmunoTherapy of Cancer · 2014 · 545 citations · Full text

Life Sciences, Immunology, Oncology +17

Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family

Ilgar Abbaszade, Rui‐Qin Liu, Fude Yang et al. · Journal of Biological Chemistry · 1999 · 489 citations · Full text

Medicine, Biochemistry, Molecular Biology +17

Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

Jordan S. Fridman, Peggy Scherle, Robert J. Collins et al. · The Journal of Immunology · 2010 · 463 citations · Full text

Medicine, Immunology, Pharmacology +17

Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β

Robert Newton, L.M. Kuitert, Martin Bergmann et al. · Biochemical and Biophysical Research Communications · 1997 · 387 citations

Life Sciences, Immunology, Molecular Biology +14